Praco: The company has obtained a new animal drug registration certificate.

The PLC announcement stated that the company had jointly applied for the "Chicken Newcastle Disease and Infectious Bronchitis Bivalent Heat-Stable Live Vaccine" with other units, which is a new veterinary drug. The company released the "New Veterinary Drug Registration Certificate" on July 17, 2025. The vaccine uses the SZ160 strain as a domesticated and weakened strain of the prevalent QX-type strain, with characteristics such as high reproductive performance, high safety, rapid immune response, and long-lasting immunity. It can effectively prevent and control the currently prevalent chicken infectious bronchitis disease in China. The launch of this product will enrich the company's poultry vaccine product lineup, enhance market competitiveness, and bring new growth opportunities for the company.